Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose folic acid for prevention of congenital anomalies
2008-004334-25Phase 3Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of folic acid in birth defect (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Rate of congenital anomalies. Started Aug 2008; status: terminated.
02
Drugs
folic acid
03
Conditions
birth defect
Beyond the preview
Go deeper on 2008-004334-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004334-25.